Abstract:Objective To assess the impact of pre-transplantation characteristics on the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with hematological malignancies. Methods The outcomes of 100 hematological malignancy patients received allo-HSCT (male 63, female 37; median age 34) were retrospectively analyzed. Forty six patients received allo-HSCT from human leucocyte antigen (HLA)-matched sibling donors and 54 from HLA-matched unrelated donors (n=51) or haploidentical donor (n=3). Twenty-four patients were diagnosed as having chronic myeloid leukemia (CML) and 37 with acute myeloid leukemia (AML), 36 with acute lymphocytic leukemia (ALL) and 3 with myelodysplasia syndrome (MDS). Among these patients, 78 patients were transplanted with disease in early stage and 22 patients in advanced stage. Univariate and multivariate analysis were performed to identify the potential prognostic factors of allo-HSCT outcome in terms of overall survival (OS), transplantation related mortality (TRM) and relapse rate (RR) which include age, sex, donor type, source of stem cell (bone marrow vs peripheral blood), donor/recipient sex mismatch, pre- transplantation disease status and time from diagnosis to transplantation. Results The 100 patients were followed-up for a median of 24(1-84) mouths after transplantation with an estimated 5-year OS rate of (59.9±7.2)%, 5-year TRM of (24.9±6.5)% and 5-year RR of (22.4±5.9)%. Univariate analysis demonstrated that pre-transplantation disease status was correlated with OS, TRM and RR while the time from diagnosis to transplantation was correlated with OS and TRM. Multivariate analysis showed that disease status was the independent prognostic factor for both OS and RR while the time from diagnosis to transplantation was the independent prognostic factor for TRM. Conclusions Pre-transplantation disease status and time from diagnosis to transplantation were the prognostic factors for allo-HSCT in patients with hematological malignancies. Early transplantation is critical for achieving a good long-term outcome.

Impact of Pre-Transplantation Characteristics on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies: a Retrospective Analysis of 100 Cases